---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292911963.md"
description: "Arbutus Biopharma shares are trading higher after the company announced the filing of three international lawsuits seeking to enforce patent protecting LNP technology against Pfizer, BioNTech and certain or other affiliates."
datetime: "2026-07-16T13:08:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292911963.md)
  - [en](https://longbridge.com/en/news/292911963.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292911963.md)
---

# 

Arbutus Biopharma shares are trading higher after the company announced the filing of three international lawsuits seeking to enforce patent protecting LNP technology against Pfizer, BioNTech and certain or other affiliates.

### Related Stocks

- [BNTX.US](https://longbridge.com/en/quote/BNTX.US.md)
- [ABUS.US](https://longbridge.com/en/quote/ABUS.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)

## Related News & Research

- [BioNTech's next act has nothing to do with COVID. Here's the $500 billion market some investors are ignoring](https://longbridge.com/en/news/293678105.md)
- [EU authorizes Pfizer-BioNTech XFG-adapted COVID vaccine for ages 6 months and up](https://longbridge.com/en/news/294258331.md)
- [BioNTech (BNTX) Stock May Look Fully Priced As Pipeline Hopes Build](https://longbridge.com/en/news/293835658.md)
- [Pfizer (PFE) Expected to Announce Earnings on Tuesday](https://longbridge.com/en/news/294078311.md)
- [Pfizer Prepares Global Regulatory Litfulo Filings Following Skin Pigment Improvements In Late-Stage Trials](https://longbridge.com/en/news/294393650.md)